All Insights
Showing 13 - 24 of 70
Life Sciences and Healthcare
2022 Finance Act increases State investment in Italian national health system
Pharmaceutical spending ceilings are increased and reforms to technical standards are expected
Life Sciences and Healthcare
Global healthcare's embrace of patient support programmes spurs regulatory action
Support programmes for patients are proliferating and regulators are looking to intervene in their international development
Corporate
Predictions 2022: What could be in store for US and international business?
Businesses will be readying themselves for growth and transformation in a year in which the world hopes to move on
Life Sciences and Healthcare
Are European advertising laws ready for patient support programmes?
The legal situation in Europe regarding advertisement of PSPs is highly fragmented with different jurisdictions taking varying approaches to address
Intellectual property
Trade secrets remain the sticking point in global debate over a vaccine IP waiver
A consensus on the vaccine IP waiver is yet to be reached, but will the cancellation of WTO's 12th Ministerial
Hemp tea - the fine line between food and narcotics
The first article from our series "Cannabis - the 'green gold' from a legal perspective"
Life Sciences and Healthcare
Debate intensifies over a vaccine IP waiver's impact on future pharma and biotech discoveries
Does a proposed patent suspension backed by Washington open a Pandora's box for vaccine R&D and investment?
Life Sciences and Healthcare
Queen's Speech 2021 sets out ambitious agenda for UK life sciences and healthcare
New parliamentary term will be packed with legislation for life sciences and healthcare businesses
Life Sciences and Healthcare
Patents Court upholds validity of second medical use patent for glaucoma treatment
This decision shows the court assessing patentability in a real-world practical context, recognising the uncertainties of R&D that only later
Life Sciences and Healthcare
Support programmes offer global healthcare ways to meet patients' needs
With technological advances increasing access to patient support programmes, what legal and regulatory issues do pharmaceutical companies need to take
